# FDA Inspection 646619 - Baptist Health Hardin - February 12, 2010

Source: https://www.keypedia.com/records/fda_inspections/baptist-health-hardin/ecf687aa-ea52-4d88-b7dc-244c8fe3a1b5
Source feed: FDA_Inspections

> FDA Inspection 646619 for Baptist Health Hardin on February 12, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 646619
- Company Name: Baptist Health Hardin
- Inspection Date: 2010-02-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1156222 - 2021-10-29](https://www.keypedia.com/records/fda_inspections/baptist-health-hardin/8514bdaa-747b-47d3-80eb-450723eab030)
- [FDA Inspection 1156222 - 2021-10-29](https://www.keypedia.com/records/fda_inspections/baptist-health-hardin/95a856b0-2a71-4996-966a-f705ce06e85b)
- [FDA Inspection 1050606 - 2018-05-01](https://www.keypedia.com/records/fda_inspections/baptist-health-hardin/eba5fee0-b8f4-4dfb-aff8-0138a98d1a18)
- [FDA Inspection 956230 - 2016-01-13](https://www.keypedia.com/records/fda_inspections/baptist-health-hardin/c6ee5b37-8330-4abd-b467-9b229a6254e3)
- [FDA Inspection 917307 - 2015-03-03](https://www.keypedia.com/records/fda_inspections/baptist-health-hardin/9926f81f-3428-4380-b216-97119c9538fa)

Company: https://www.keypedia.com/companies/baptist-health-hardin/f4fd7f80-6b5d-40db-9c56-1863941c5298

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d